Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
BMS-790052
Cat No.
CEI-0221
Description
As a highly selective inhibitor, BMS-790052 can inhibit HCV NS5A with EC50 of 9-50 pM.
CAS No.
1214735-16-6
Molecular Weight
738.88
Purity
>99%
Storage
2 years at -20 centigrade
Targets
HCV
Molecular Formula
C40H50N8O6
Chemical Name
Carbamic acid, N,N-[[1,1-biphenyl]-4,4-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C-dimethyl ester
Solubility
DSMO 148 mg/mL Water
In vitro
BMS-790052 is the most potent hepatitis C virus (HCV) inhibitor. By targeting nonstructural protein 5A (NS5A), BMS-790052 is different from most HCV inhibitors. BMS-790052 is highly effective against genotype 1 replicons and also displays robust genotype 1 anti-HCV activity in the clinic. BMS-790052 can inhibit genotype 1 replicons with EC50 of less than 50 pM. BMS-790052 inhibits genotype 2a JFH1 replicon cells and cell culture infectious virus with EC50 of 46.8 pM and 16.1 pM. BMS-790052 blocks the cis-acting function of NS5A. Since BMS-790052 also impairs JFH1 NS5A hyperphosphorylation, it likely also blocks the trans-acting function.
In vivo
BMS-790052 shows potent antiviral effect in vivo. Although resistance emerged during monotherapy with BMS-790052, the substantial anti-HCV effect of this compound makes it an excellent candidate for effective combination therapy.
Download
Download Datasheet